Presented by Elizabeth Elliott, PMHNP-BC. Lunch will be provided. Attendees will be admitted on a first-come basis. Long-term care residents with tardive dyskinesia require special considerations. Learn about phenomenology, prevalence, and management guidelines for tardive dyskinesia in this population. Faculty will share clinical data for an FDA-approved treatment option for adults with tardive dyskinesia and highlight data from a post hoc analysis of safety and efficacy for adults aged 65 years and older. Supported by Neurocrine Biosciences, Inc.